Vaseem Mahboob insider trades: Kestra Medical Technologies (KMTS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vaseem reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | KMTS | ↓ Sell | 79,500 | $30.30 | $2.4M | Direct | Oct 29, 2026 (0d) |
| Aug 7, 2026 | KMTS | ↓ Sell | 26,287 | $25.88 | $680K | Direct | Aug 11, 2026 (4d) |
| Aug 3, 2026 | KMTS | ↓ Sell | 18,188 | $22.99 | $418K | Direct | Aug 3, 2026 (0d) |
| Apr 3, 2019 | ELGX | ↑ Buy | 15,128 | $6.61 | $100K | Direct | Apr 3, 2019 (0d) |
| Aug 16, 2018 | ELGX | ↑ Buy | 30,000 | $2.43 | $73K | Direct | Aug 20, 2018 (4d) |
| Dec 13, 2016 | ELGX | ↑ Buy | 20,000 | $6.25 | $125K | Direct | Dec 15, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KMTS insiders
Open-market trades in the last 12 months
About Vaseem Mahboob's insider trades
Vaseem Mahboob is Chief Financial Officer at Kestra Medical Technologies (KMTS). Since Dec 13, 2016, Vaseem has reported 3 open-market purchases worth $298K and 3 sales worth $3.5M on SEC Form 4. In the last 12 months: 3 sales ($3.5M).
Their filings also include grants and awards (20 filings), shares withheld for taxes (7 filings), shares returned to the company (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KMTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.